MALIGNANT SOLID TUMOR
Clinical trials for MALIGNANT SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT SOLID TUMOR trials appear
Sign up with your email to follow new studies for MALIGNANT SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo targets Hard-to-Treat brain tumors from cancer
Disease control Not yet recruitingThis study is testing a combination of three drugs (utidelone, bevacizumab, and sometimes etoposide) for patients whose cancer has spread to the brain. The goal is to see if this treatment can shrink the brain tumors and control the cancer for a longer time. It is for people with…
Matched conditions: MALIGNANT SOLID TUMOR
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Scientists test One-Shot cancer drug combo in Early-Stage trial
Knowledge-focused Not yet recruitingThis is a very early, small study to see if a single dose of two immunotherapy drugs can change the immune cells inside certain stomach and esophageal tumors. It will involve 34 adults with early-stage cancer who have a specific genetic change (ARID1A mutation) and have not had a…
Matched conditions: MALIGNANT SOLID TUMOR
Phase: EARLY_PHASE1 • Sponsor: University of California, Irvine • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC